Open access · OA
via Europe PMC
Kampo medicine as a nutrition-relevant multi-target intervention for sarcopenia: implications for appetite, mitochondrial function, and the frailty-sarcopenia-cachexia continuum.
Frontiers in nutrition · 2026
Abstract
<h4>Background</h4>Sarcopenia is sustained not only by age-related declines in muscle anabolism but also by reduced nutritional intake, anorexia, metabolic dysregulation, mitochondrial dysfunction(definition), chronic inflammation, neuromuscular deterioration, and physical inactivity. Accordingly, interventions that influence appetite, oral intake, nutrient handling, fatigue, metabolic resilience, and physical function may be relevant within multimodal sarcopenia care. Kampo medicine, a traditional Japanese system of standardized multi-component herbal formulations, may be positioned as a nutrition-relevant multi-target intervention; however, its clinical evidence base for sarcopenia remains heterogeneous and largely indirect.<h4>Methods</h4>We conducted a narrative review of published clinical, translational, and mechanistic literature addressing sarcopenia, frailty, cachexia, nutrition-related muscle wasting, the gut-muscle axis, systems pharmacology, and representative pharmaceutical-grade Kampo formulations. Searches were performed in PubMed, Scopus, and Web of Science from database inception to May 2026 using prespecified combinations of disease-, mechanism-, and formula-specific terms, supplemented by an additional search for Juzentaihoto/Juzen-taiho-to and related transliterations in response to peer review. Evidence was interpreted according to whether it directly evaluated sarcopenia outcomes or indirectly addressed nutrition-relevant domains such as appetite, fatigue, inflammation, mitochondrial function, physical activity, or neuromuscular symptoms.<h4>Results</h4>Sarcopenia shares important pathophysiological features with frailty and cachexia, including chronic inflammation, impaired mitochondrial function, anabolic resistance, reduced food intake, fatigue, and neuromuscular dysfunction. Several Kampo formulations, including Ninjin'yoeito, Rikkunshito, Hochuekkito, Juzentaihoto, Hachimijiogan, and Goshajinkigan, have been associated with biological or clinical domains potentially relevant to appetite regulation, oral intake, inflammatory balance, gut microbiota-related pathways, metabolic resilience, and functional support. Nevertheless, direct evidence using standardized sarcopenia criteria and validated endpoints remains limited.<h4>Conclusion</h4>Kampo medicine is best regarded as a hypothesis-generating, nutrition-relevant complementary approach within multimodal sarcopenia care rather than as an established stand-alone therapy for muscle loss. Future studies should use standardized diagnostic criteria, prespecified sarcopenia endpoints, rigorous safety monitoring, and transparent reporting to determine whether selected Kampo formulations can improve clinically meaningful nutrition-related and muscle-related outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fnut.2026.1871481
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
T, K., & T., K. (2026). Kampo medicine as a nutrition-relevant multi-target intervention for sarcopenia: implications for appetite, mitochondrial function, and the frailty-sarcopenia-cachexia continuum. <em>Frontiers in nutrition</em>. https://doi.org/10.3389/fnut.2026.1871481
Vancouver
T K, T. K. Kampo medicine as a nutrition-relevant multi-target intervention for sarcopenia: implications for appetite, mitochondrial function, and the frailty-sarcopenia-cachexia continuum. Frontiers in nutrition. 2026. doi:10.3389/fnut.2026.1871481.
BibTeX
@article{kurokawa2026Kampom,
title = {Kampo medicine as a nutrition-relevant multi-target intervention for sarcopenia: implications for appetite, mitochondrial function, and the frailty-sarcopenia-cachexia continuum.},
author = {Kurokawa T and Kurokawa T.},
journal = {Frontiers in nutrition},
year = {2026},
doi = {10.3389/fnut.2026.1871481},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Yeungnam medical science 2026
Citation only
Metabolic sarcopenia in the era of incretin-based therapy: a narrative review of mitochondrial determinants of muscle quality and emerging therapeutic strategies.
Endocrinology and Metabolism 2026
Open access · CC-BY
Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics
Biological trace element research 2026
Citation only
Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.
International Journal of Molecular Sciences 2023
Open access · CC-BY
Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
Current nutrition reports 2026
Open access · OA
Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
Selcuk University 2025
Open access · US-GOV